Shares of MiniMed Group Inc (NASDAQ:MMED – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as $11.52 and last traded at $11.68, with a volume of 452520 shares trading hands. The stock had previously closed at $11.87.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Wells Fargo & Company started coverage on shares of MiniMed Group in a research note on Tuesday, March 31st. They issued an “overweight” rating and a $26.00 target price for the company. The Goldman Sachs Group started coverage on shares of MiniMed Group in a research note on Tuesday, March 31st. They set a “buy” rating and a $24.00 price objective on the stock. Bank of America started coverage on shares of MiniMed Group in a research note on Tuesday, March 31st. They set a “buy” rating and a $27.00 price objective on the stock. Citigroup started coverage on shares of MiniMed Group in a research note on Tuesday, March 31st. They set a “buy” rating and a $23.00 price objective on the stock. Finally, William Blair started coverage on shares of MiniMed Group in a research note on Tuesday, March 31st. They set an “outperform” rating on the stock. Eleven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $22.45.
Get Our Latest Analysis on MiniMed Group
MiniMed Group Stock Performance
MiniMed Group Company Profile
We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.
Recommended Stories
Receive News & Ratings for MiniMed Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiniMed Group and related companies with MarketBeat.com's FREE daily email newsletter.
